Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03982901
Other study ID # 2019298H(R3)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 18, 2019
Est. completion date April 29, 2021

Study information

Verified date August 2020
Source Guangdong Provincial People's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Mental stress-induced myocardial ischemia(MSIMI) has been recognized a significant clinical problem. Evidence has shown that individuals with MSIMI have 2 to 2.5 times higher risk to develop a major averse cardiovascular events over 3-5 years, compared to their counterparts who have no MSIMI. Nevertheless, investigations into the study of MSIMI among women who have chest pain but artery stenosis < 50% have been lacking. In this project, the investigators used positron emission tomography (PET) to evaluate perfusion defect during mental stress to diagnose MSIMI. Women with chest pain and coronary artery stenosis < 50% were included as the experimental group, age-matched healthy people as the control group, the aim of this study is to compare the incidence of MSIMI in the two groups. At the same time, the study also observe the change of MBF during mental stress and the relationship between MBF and MSIMI.


Description:

The goals of this project are to assess MSIMI prevalence in chest pain women with coronary artery stenosis less than 50%, as compared to age matched healthy women, and the MBF change during mental stress and adenosine vasodilator stress by PET with N-13 ammonia . This study will also establish the methodology of echocardiography to diagnose MSIMI by comparing with PET. To evaluate the consistency of myocardial blood flow (MBF by PET-CT) and peripheral blood flow (PAT ratio by EndoPAT) during stress test. and to explore the pathogenesis of MSIMI from aspects of neuroendocrine mechanism, sex hormone level, humoral immunity index and proteome expression. The stress testing will be conducted at the PET-CT and echocardiography unit of Guangdong Provincial People's Hospital. Following a 20-minute calibration-rest period, participants will be asked to complete a series of 3 consecutive mental stress tasks. The mental stress tests are embedded in the virtual reality device, and the subjects can carry out the mental stress test with the virtual reality device on their heads. (1) Stroop Color-Word test, is administered by computer on a video monitor. A word appeared in the middle of the screen-Red, Green, Yellow, or Blue-in one of these four colors. At the bottom of the screen the words Red, Green, Yellow, and Blue appeared with the font color not matching the word meaning. The participant is asked to match the color of the word in the middle of the screen with the meaning of the color word at the bottom by clicking on the correct option, which lasts about 4 minutes. and then (2) Public speaking with anger recall: during this test, patients will be asked to give a speech on a recent situation in which they experienced anger to an audience of three observers (doctors) after 1 minute of preparation. Prior to the speech, subjects are told that their speech will be evaluated on their description of the situation, as to what happened, what they thought, felt, what they did, and what happened as a result. If they run out of things to say, the research tech will prompt them with questions to elicit more content until the three minutes are up. and at last the (3) Mental arithmetic: during this test, patients will be asked to perform a series of serial subtractions beginning at a given number which will be different for each repeated test and will be chosen by the tester from a fixed list of various numbers, with encouragement to perform calculations as quickly as possible; Each mental stress lasts for 4 minutes, there is no rest between the two mental stress, and the whole process of mental stress is 12 minutes.


Recruitment information / eligibility

Status Completed
Enrollment 126
Est. completion date April 29, 2021
Est. primary completion date April 29, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 75 Years
Eligibility The inclusion criteria are as follows: 1) Women with chest pain and coronary artery stenosis < 50% 2) Participate in the trial voluntarily and sign the informed consent form; 3) older than 18 and less than 75 years old, female; 4) be able to cooperate with the completion of evaluation and inspection. Exclusion criteria. 1. Chest pain caused by diseases other than the cardiovascular system such as Aortic dissection, Pulmonary embolism; 2. Combined with pulmonary embolism; 3. Combined with aortic dissection; 4. A serious life-threatening arrhythmias; 5. Combined with cardiomyopathy or severe valvular disease; 6. New York Heart Association(NYHA) class IV; 7. Recent myocardial infarction within 1 month; 8. Combined with severe mental illness, such as schizophrenia, Active suicidal ideation etc. 9. History of substance and alcohol abuse in the previous 12 months; 10. Significant cardiac, pulmonary, metabolic, renal, hepatic disease, or malignancy, interfering with patient's participation in this study; 11. Currently taking antidepressant or antianxiety medications within 1 month; 12. Participated in other clinical trials within 3 months; 13. Cognitive impairment or inability to cooperate with researchers.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Mental Stress Test
In this study, we compare MSIMI prevalence in the two groups (chest pain group and no chest pain group). Each subject in both groups receive the same mental stress test process, and the mental stress test process have 3 consecutive stress tests, which including: Stroop Color-Word test; Public speaking with anger recall test and Mental arithmetic test.

Locations

Country Name City State
China Guangdong Provincial People's Hospital Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Guangdong Provincial People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary MSIMI (Measures as perfusion deficit with mental stress test via PET-CT) prevalence in chest pain women with coronary artery stenosis less than 50%, as compared to age matched healthy women. Percentage of participants wih an presence of mental stress-induced myocardial ischemia (MSIMI) during the 3 mental stressors.
MSIMI is defined by the following: compared to rest, 1) Each myocardial segment was scored from 0 to 4, with 0 being normal, 1 possibly normal, 2 definitely abnormal, 3 severely abnormal, and 4 no perfusion. The investigators calculated summed scores in a conventional fashion, including a summed stress score, a summed rest score, and a summed difference score. A summed difference score =3 is typically used as evidence of MSIMI.
half an hour
Primary The MBF change during mental stress test The MBF change during mental stress test half an hour
Secondary Blood flow reserve in women with chest pain and coronary artery stenosis < 50% . Bood flow reserve of participants using Adenosine half an hour
Secondary The consistency of PET-CT myocardial scanning and color Doppler echocardiography (contrast echocardiography, spot tracking) for the diagnosis of MSIMI. The consistency between PET-CT and Doppler echocardiography (contrast echocardiography, spot tracking) in diagnosing MSIMI 30 days
Secondary The consistency of myocardial blood flow (MBF by PET-CT) and peripheral blood flow (PAT ratio by EndoPAT) under pressure test. The consistency between myocardial blood flow and peripheral blood flow during mental stress test 2 hours
Secondary The neuroendocrine change in MSIMI(+) group, as compared with MSIMI(-) group. The cause of MSIMI 1 hour
Secondary The difference of sex hormone level between MSIMI(+) group and MSIMI(-) group The cause of MSIMI 1 hour
Secondary The difference of humoral immunity index level between MSIMI(+) group and MSIMI(-) group. The cause of MSIMI 1 hour
Secondary The difference of proteome expression level between MSIMI(+) group and MSIMI(-) group. The cause of MSIMI 2 days
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06083155 - The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
Recruiting NCT04827498 - Myocardial Ischemia Without Obstructive Coronary Stenoses
Recruiting NCT06327672 - INOCA Spanish National Registry
Recruiting NCT06413641 - VIsualization of Coronary Artery Disease for Modification of RISK Factors N/A
Completed NCT05471739 - Simultaneous Assessment of Coronary Microvascular Dysfunction and Ischemia With Non-obstructed Coronary Arteries With Intracoronary Electrocardiogram and Intracoronary Doppler
Recruiting NCT05031520 - PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease
Recruiting NCT05035056 - WARRIOR Ancillary Study for CCTA Analysis
Completed NCT04186676 - Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population
Recruiting NCT04805814 - Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial N/A
Recruiting NCT04674449 - iCorMicA - Stratified Medicine in Angina N/A